Results 61 to 70 of about 611,536 (212)

Keratinocyte Priming by Staphylococcus aureus Reduces HSV‐1 Susceptibility

open access: yesAllergy, EarlyView.
ADEH+ patients have a reduced microbial diversity with increased S. aureus and S. epidermidis colonization compared to ADEH− and healthy controls. Heat‐killed S. aureus reduced HSV‐1 susceptibility and release of infectious progeny virus in a keratinocyte in vitro model. Heat‐killed S.
Phila Cara Baumann   +19 more
wiley   +1 more source

Meningoencephalomyelitis associated with Epstein-Barr virus infection: one case report

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2017
DOI: 10.3969/j.issn.1672-6731.2017.11 ...
Dan-dan SONG   +4 more
doaj  

Considerations about gastric cancer proteomics

open access: yesRevista do Colégio Brasileiro de Cirurgiões
The frequency of molecular studies aimed to analyze promoter methylation of tumor suppressor genes and global proteomics in gastric carcinogenesis is increasing.
CARLOS EDUARDO CARVALHO   +6 more
doaj   +1 more source

Key insights into biosecurity risks, communication preferences and behaviour change drivers among livestock transporters in Australia

open access: yesAustralian Veterinary Journal, EarlyView.
The transportation of livestock poses an increased risk of disease transmission, with transportation vehicles acting as vectors for disease. Biosecurity management within the livestock industry is therefore critical to reduce the risk of disease transmission. This study investigated the current biosecurity practices of stakeholders within the livestock
M Hernandez‐Jover   +3 more
wiley   +1 more source

A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis

open access: yesThe Korean Journal of Gastroenterology, 2016
Epstein-Barr virus (EBV) causes various acute and chronic diseases. Chronic active EBV infection (CAEBV) is characterized by infectious mononucleosis-like symptoms that persist for more than 6 months with high viral loads in peripheral blood and/or an ...
Ja In Lee   +8 more
doaj   +1 more source

Human herpesvirus 4 and adaptive immunity in Alzheimer’s disease [PDF]

open access: yesSignal Transduction and Targeted Therapy, 2020
Jian-Sheng Kang, Pei-Pei Liu
openaire   +2 more sources

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Clinical and genetic characterization of intellectual disability

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
This study examines the etiological factors and comorbidities in a large cohort of Finnish patients with intellectual disability. Genetic causes—including chromosomal abnormalities and pathogenic gene variants—were more frequently identified in individuals with moderate to profound intellectual disability.
Aarni Venetvaara   +14 more
wiley   +1 more source

Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma

open access: yesVirology Journal, 2010
The application of gene therapy for malignant gliomas is still under study and the use of specific vectors represents an important contribution. Here, we investigated bovine herpesvirus 4 (BoHV-4), which is non-pathogenic if injected into the rodent ...
D'Avella Domenico   +7 more
doaj   +1 more source

Outcomes of Kaposi sarcoma in people living with HIV who maintain long‐term viral suppression: A prospective case‐series

open access: yesHIV Medicine, EarlyView.
Abstract Background Data on chemotherapeutic efficacy and tolerability for Kaposi Sarcomas (KS) in people living with HIV (PWH) and HIV‐virological control are limited. We aimed to describe clinical responses and tolerability of KS therapies in PWH with HIV‐aviraemic KS in a prospective cohort.
S. Bacquart   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy